FDA — authorised 13 February 1990
- Application: NDA019886
- Marketing authorisation holder: PFIZER
- Local brand name: SYNAREL
- Indication: SPRAY, METERED — NASAL
- Status: approved
🇺🇸 Synarel in United States
FDA authorised Synarel on 13 February 1990
Marketing authorisations
FDA
- Status: approved
Pricing & reimbursement
- annual_list: USD 80000.00 per year
Synarel in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Synarel approved in United States?
Yes. FDA authorised it on 13 February 1990; FDA has authorised it.
Who is the marketing authorisation holder for Synarel in United States?
PFIZER holds the US marketing authorisation.
What does Synarel cost in United States?
annual_list: USD 80000.00 per year. Final patient cost depends on reimbursement and any patient access scheme.